Sequoia Financial Advisors LLC Has $1.75 Million Stock Position in HCA Healthcare, Inc. $HCA

Key Points

• Sequoia Financial Advisors LLC increased its stake in HCA Healthcare by 41.4% in Q2, holding shares valued at approximately $1.75 million after acquiring an additional 1,334 shares.
• HCA Healthcare reported a quarterly EPS of $6.84, exceeding expectations, along with a revenue of $18.61 billion, indicating a 6.4% year-over-year growth.
• The company recently announced a quarterly dividend of $0.72 per share, translating to an annualized yield of 0.7% and a dividend payout ratio of 12.11%.

Sequoia Financial Advisors LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 41.4% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,559 shares of the company's stock after purchasing an additional 1,334 shares during the quarter. Sequoia Financial Advisors LLC's holdings in HCA Healthcare were worth $1,747,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Mitchell Sinkler & Starr PA acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth about $215,000. CWM LLC grew its holdings in HCA Healthcare by 5.4% during the 2nd quarter. CWM LLC now owns 13,062 shares of the company's stock worth $5,004,000 after acquiring an additional 667 shares during the last quarter. OFI Invest Asset Management grew its holdings in HCA Healthcare by 9.4% during the 2nd quarter. OFI Invest Asset Management now owns 63,826 shares of the company's stock worth $24,452,000 after acquiring an additional 5,483 shares during the last quarter. Vanguard Personalized Indexing Management LLC grew its holdings in HCA Healthcare by 22.0% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 38,771 shares of the company's stock worth $14,854,000 after acquiring an additional 6,997 shares during the last quarter. Finally, Concurrent Investment Advisors LLC grew its holdings in HCA Healthcare by 4.3% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 2,235 shares of the company's stock worth $856,000 after acquiring an additional 93 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $419.53 on Friday. The company's 50 day simple moving average is $409.17 and its 200 day simple moving average is $377.66. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $439.01. The firm has a market capitalization of $98.17 billion, a price-to-earnings ratio of 17.63, a PEG ratio of 1.33 and a beta of 1.40.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business's quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the company posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 1.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on HCA shares. UBS Group increased their price objective on shares of HCA Healthcare from $438.00 to $495.00 and gave the stock a "buy" rating in a report on Tuesday. The Goldman Sachs Group initiated coverage on shares of HCA Healthcare in a research note on Tuesday. They issued a "buy" rating and a $470.00 target price on the stock. Wells Fargo & Company raised their target price on shares of HCA Healthcare from $375.00 to $412.00 and gave the company an "equal weight" rating in a research note on Tuesday, October 7th. Weiss Ratings reaffirmed a "buy (b-)" rating on shares of HCA Healthcare in a research note on Wednesday, October 8th. Finally, Truist Financial set a $460.00 target price on shares of HCA Healthcare in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $431.07.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.